|
Real-time Estimate
Cboe BZX
12:37:04 11/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 38.25 USD | -1.37% |
|
-3.61% | +39.73% |
| Market Cap | 3.05B 2.62B 2.47B 2.25B 4.21B 290B 4.22B 29.24B 11.3B 148B 11.44B 11.19B 468B | P/E 2026 * |
-9.24x | P/E 2027 * | -9.15x |
|---|---|---|---|---|---|
| Enterprise Value | 2.38B 2.05B 1.93B 1.76B 3.29B 227B 3.3B 22.88B 8.84B 116B 8.95B 8.75B 366B | EV / Sales 2026 * |
1,173x | EV / Sales 2027 * | 189x |
| Free-Float |
99.73% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CLDX | Delayed | |
CBOE
| CLDX | Real-time | |
|
Boerse Muenchen
| TCE2 | Real-time | |
|
Börse Stuttgart
| TCE2 | Delayed | |
|
Tradegate
| TCE2 | Real-time | |
|
Deutsche Boerse AG
| TCE2 | Delayed | |
|
Berne S.E.
| TCE1 | End-of-day quote |
Last Transcript : Celldex Therapeutics, Inc.
| 1 day | -1.53% | ||
| 1 week | -3.61% | ||
| Current month | -4.24% | ||
| 1 month | -11.68% | ||
| 3 months | +29.30% | ||
| 6 months | +21.83% | ||
| Current year | +39.73% |
| 1 week | 37.75 |  | 40.04 |
| 1 month | 37.75 | | 45.14 |
| Current year | 22.33 | | 45.14 |
| 1 year | 22.1 | | 45.14 |
| 3 years | 14.4 | | 53.18 |
| 5 years | 14.4 | | 57.2 |
| 10 years | 1.5 | | 75.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tibor Keler
CTO | Chief Tech/Sci/R&D Officer | 67 | 30/07/2014 |
Anthony Marucci
CEO | Chief Executive Officer | 64 | 01/09/2008 |
Sam Martin
DFI | Director of Finance/CFO | 55 | 01/04/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Marucci
BRD | Director/Board Member | 64 | 01/12/2008 |
Harry Penner
CHM | Chairman | 80 | 05/06/2025 |
Herbert Conrad
BRD | Director/Board Member | 93 | 01/03/2008 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/6/26 | Free | Executive/Senior Manager | 20,000 | 0.0255% | ||
| 25/6/26 | Free | Director | 26,000 | 0.0331% | ||
| 25/6/26 | Free | Chief Technology Officer | 57,000 | 0.0726% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.37% | -3.61% | +52.04% | +37.85% | 3.05B | |
| +0.24% | -7.01% | -2.77% | +11.08% | 46.38B | |
| -1.42% | -2.00% | +410.88% | +528.69% | 44.51B | |
| -0.96% | -6.06% | +38.77% | +18.49% | 42.3B | |
| -2.32% | -5.31% | +9.39% | +64.12% | 39.91B | |
| 0.00% | -1.72% | +13.42% | +42.33% | 32.79B | |
| -0.19% | -3.70% | - | - | 17.13B | |
| -0.82% | -1.84% | +22.20% | +108.52% | 16.36B | |
| +0.08% | -3.32% | +12.84% | +31.08% | 14.31B | |
| -1.59% | -6.43% | +79.10% | +37.48% | 13.29B | |
| Average | -0.84% | -3.39% | +70.65% | +97.74% | 27B | |
| Weighted average by Cap. | -0.84% | -3.62% | +88.46% | +125.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.03M 1.75M 1.65M 1.5M 2.81M 193M 2.82M 19.51M 7.54M 98.47M 7.63M 7.46M 312M | 12.73M 10.95M 10.31M 9.4M 17.58M 1.21B 17.65M 122M 47.24M 617M 47.8M 46.76M 1.95B |
| Net income | -319M -275M -259M -236M -441M -30.37B -443M -3.06B -1.18B -15.47B -1.2B -1.17B -49.02B | -361M -311M -292M -266M -499M -34.35B -501M -3.47B -1.34B -17.5B -1.36B -1.33B -55.43B |
| Net Debt | -662M -570M -537M -489M -915M -63.02B -919M -6.36B -2.46B -32.11B -2.49B -2.43B -102B | -638M -549M -517M -471M -881M -60.67B -884M -6.12B -2.37B -30.91B -2.39B -2.34B -97.91B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | USD 38.21 | -1.47% | 85,114 |
| 09/09/26 | USD 38.78 | -0.87% | 588,415 |
| 08/09/26 | USD 39.12 | -1.41% | 834,305 |
| 04/09/26 | USD 39.68 | +0.79% | 414,532 |
| 03/09/26 | USD 39.37 | -0.28% | 417,999 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CLDX Stock
Select your edition
All financial news and data tailored to specific country editions
